203 related articles for article (PubMed ID: 20373880)
21. Pseudomonas keratitis associated with daily wear of silicone hydrogel contact lenses.
Schornack MM; Faia LJ; Griepentrog GJ
Eye Contact Lens; 2008 Mar; 34(2):124-8. PubMed ID: 18327051
[TBL] [Abstract][Full Text] [Related]
22. Ciprofloxacin monotherapy and bacterial keratitis.
Katz HR
Ophthalmology; 1999 Oct; 106(10):1853-4. PubMed ID: 10519570
[No Abstract] [Full Text] [Related]
23. [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones].
Díaz Valle D; Alós Cortés JI; Arteaga Sánchez A; Toledano Fernández N; Poza Morales Y; Díaz-Valle T
Arch Soc Esp Oftalmol; 2002 Jul; 77(7):397-9. PubMed ID: 12098814
[TBL] [Abstract][Full Text] [Related]
24. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U
Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468
[TBL] [Abstract][Full Text] [Related]
25. Nona-D-arginine amide suppresses corneal cytokines in Pseudomonas aeruginosa keratitis.
Karicherla P; Aras S; Aiyar A; Hobden JA
Cornea; 2010 Nov; 29(11):1308-14. PubMed ID: 20802321
[TBL] [Abstract][Full Text] [Related]
26. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Lee EJ; Truong TN; Mendoza MN; Fleiszig SM
Curr Eye Res; 2003 Nov; 27(5):289-99. PubMed ID: 14562165
[TBL] [Abstract][Full Text] [Related]
27. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
[TBL] [Abstract][Full Text] [Related]
28. Enoxacin therapy for experimental pseudomonas keratitis.
Esposito S; Thadepalli H; Benler HA; Chuah SK
J Chemother; 1991 Jun; 3(3):147-51. PubMed ID: 1919652
[TBL] [Abstract][Full Text] [Related]
29. Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection.
Hazlett LD; Rudner XL; McClellan SA; Barrett RP; Lighvani S
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):419-24. PubMed ID: 11818386
[TBL] [Abstract][Full Text] [Related]
30. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature.
McElvanney AM
Eye Contact Lens; 2003 Oct; 29(4):258-61. PubMed ID: 14555906
[TBL] [Abstract][Full Text] [Related]
31. Role of nitric oxide in P. aeruginosa keratitis caused by distinct bacterial phenotypes.
Wang W; Xue M; Willcox M; Thakur A
Eye Contact Lens; 2008 Jul; 34(4):195-7. PubMed ID: 18787424
[TBL] [Abstract][Full Text] [Related]
32. Regulation of Pseudomonas aeruginosa corneal infection in IL-1 beta converting enzyme (ICE, caspase-1) deficient mice.
Thakur A; Barrett RP; McClellan S; Hazlett LD
Curr Eye Res; 2004; 29(4-5):225-33. PubMed ID: 15590467
[TBL] [Abstract][Full Text] [Related]
33. Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye.
Pillar CM; Hazlett LD; Hobden JA
Curr Eye Res; 2000 Sep; 21(3):730-9. PubMed ID: 11120561
[TBL] [Abstract][Full Text] [Related]
34. Initial treatment of Pseudomonas aeruginosa contact lens-associated keratitis with topical chloramphenicol, and effect on outcome.
Bourkiza R; Kaye S; Bunce C; Shankar J; Neal T; Tuft S
Br J Ophthalmol; 2013 Apr; 97(4):429-32. PubMed ID: 23343655
[TBL] [Abstract][Full Text] [Related]
35. A case of 'double hypopyon' secondary to Pseudomonas aeruginosa keratitis in a patient with longstanding rubeotic glaucoma.
Osborne SA; Al Ahmar B; Gerges S
Acta Ophthalmol Scand; 2005 Aug; 83(4):510-1. PubMed ID: 16029282
[No Abstract] [Full Text] [Related]
36. Posterior scleritis secondary to Pseudomonas aeruginosa keratitis.
Fahim K; Houghton O; Dastjerdi M; Mian SI
Cornea; 2005 Oct; 24(7):879-81. PubMed ID: 16160510
[TBL] [Abstract][Full Text] [Related]
37. IFN-gamma: regulation of nitric oxide in the P. aeruginosa-infected cornea.
McClellan SA; Lighvani S; Hazlett LD
Ocul Immunol Inflamm; 2006 Feb; 14(1):21-8. PubMed ID: 16507487
[TBL] [Abstract][Full Text] [Related]
38. Use of aprotinin in the treatment of pseudomonas corneal ulceration.
Stuart JC; Turgeon P; Kowalski RP
Trans Pa Acad Ophthalmol Otolaryngol; 1989; 41():823-6. PubMed ID: 2483595
[No Abstract] [Full Text] [Related]
39. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
[TBL] [Abstract][Full Text] [Related]
40. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
